Hong Kong stock market movers | Pharmaceutical stocks continue to strengthen, with Sino Biopharm leading gains after securing a US$7 billion BD deal; BD out-licensing in the first three quarters nears last year's full-year level.

Zhitong Finance APP has learned that pharmaceutical stocks continued to rise this morning, led by innovative drugs and CRO concepts. As of press time, Sino Biopharmaceutical (01177.HK) rose 8.64% to HK$5.595; Akeso (09926.HK) rose 5.76% to HK$87.25; BeiGene (06160.HK) rose 5.61% to HK$244.6; Innovent Biologics (01801) rose 4.70% to HK$89.05; Kelun-Biotech (06990) rose 4.66% to HK$463.0; WuXi AppTec (02359) rose 4.65% to HK$207.0.